AMRN Amarin: Nilai bisnis marang pendapatan

amarincorp.com (AMRN) - logo korporat

High testing costs and patent protection create barriers, which validates the EV/Sales multiple on the current GURU.Markets platform chart, where the -459.44 level reflects the current value for Amarin Corporation plc (AMRN). Growth relies on the commercialization of Vascepa and cost optimization. However, generic expansion in the US limits potential, forcing management to focus on European sales markets.

AMRN - Rasio nilai perusahaan marang pendapatan Amarin ing rentang 23.11.2025 - 20.11.2026

Amarin Corporation - rincian analitis lan metrik utama (AMRN)

- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- indikator dhuwit lan arus kas:
Pambiji fundamental:Amarin Corporation plc (AMRN)
Sampel barang Amarin

This metric is sensitive to changes in market capitalization and net debt, allowing for a real-time assessment of business value. It measures the market price of an asset per unit of revenue, excluding the impact of leverage. For Amarin Corporation plc (AMRN), this reflects the monetization efficiency of cardiovascular drugs, accounting for the costs of environmental modernization at its plants. It is critical for investors to benchmark this data against industry medians. The dynamics of these processes are clearly illustrated on this EV/Revenue chart.